2025 年 4 月 29 日，山东大学姜新义教授、史本康教授、荆卫强等人在 Nature 子刊 Nature Cancer 上发表了题为：An in situ engineered chimeric IL-2 receptor ...

This study exploring the role of TRPV1 signaling in recruiting macrophages and promoting angiogenesis during tympanic membrane wound healing presents useful findings. However, the strength of evidence ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

In order to address the challenge of sepsis treatment through immune metabolic modulation, the research team led by Prof.

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, presented noteworthy new data at the American Association for ...

At the beginning of 2025, UC Santa Barbara assistant professor in Molecular, Cellular and Developmental Biology Meghan Morrissey was granted the Damon Runyon-Rachleff Innovation Award for her research ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

“To investigate the basis for treatment failure ... axis functions as an immunosuppressive switch in macrophages that maintains a T cell–deprived TME, thus posing a major barrier to effective ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Their findings could open up a new avenue for precision therapy for what is the most ... that the metabolic interplay between cancer cells and macrophages plays a dominant role in arginine-driven ...